You are here: Industry Insights > trial

News List

PolyPid Completes Enrollment of Trial for D-PLEX100 in Abdominal Surgery americanpharmaceuticalreview
August 13, 2019
PolyPid has completed patient enrollment of 200 patients in its Phase 2 clinical trial evaluating D-PLEX100 for the prevention of post-abdominal surgery incisional site infections.
Clinical trial reporting is improved by professional medical writers europeanpharmaceuticalreview
August 13, 2019
A new systematic review has shown that the speed and quality of clinical trial reports are improved by professional medical writers.
89bio Initiates Trial of BIO89-100 for NASH americanpharmaceuticalreview
August 09, 2019
89Bio announced the first patients have been screened in its proof of concept Phase 1b/2a clinical trial evaluating its investigational product candidate, BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 (FGF21) ...
Researchers 'Spin' Clinical Trial Findings in Top Psych Journals drugs
August 07, 2019
Summary results of clinical trials published in top journals are often exaggerated, a new review charges.The review says such spin -- exaggerating the clinical significance of a treatment without...
Stero Biotechs to Commence Phase 2a Trial of Cannabidiol-Based Formulation for Crohn's Disease americanpharmaceuticalreview
July 24, 2019
Stero Biotechs received its second Helsinki approval to move forward with a second Phase 2a clinical trial. The trial will be a randomized, double-blind, placebo-controlled, multicenter study of ST-SDCD-01 ...
PMZ-1620 Enters Phase III Trial in Patients with Cerebral Ischemic Stroke americanpharmaceuticalreview
July 22, 2019
Pharmazz has received permission to initiate a prospective, multicentric, randomized, double-blind, parallel, phase III clinical study to assess efficacy of PMZ-1620 along with standard treatment in patients of acute ischemic stroke in India.
DRC rejects clinical trial for experimental Ebola vaccine europeanpharmaceuticalreview
July 19, 2019
The health minister for the Democratic Republic of the Congo has stated an experimental Ebola vaccine will not be trialled in the country.
Review evaluates how AI could boost the success of clinical trials worldpharmanews
July 19, 2019
Review evaluates how AI could boost the success of clinical trials.
AM-Pharma raises €116m to support SA-AKI Phase III trial pharmaceutical-technology
July 17, 2019
Dutch biopharmaceutical company AM-Pharma has raised €116m from a European syndicate of new and existing investors.
TARIS Initiates Clinical Trial of TAR-200, Opdivo® Combo americanpharmaceuticalreview
July 12, 2019
TARIS Bio™ announced the dosing of the first patient in a Phase 1b clinical trial evaluating the investigational product TAR-200 in combination with Opdivo® (nivolumab), a programmed death-1 (PD-1) immune checkpoint inhibitor from Bristol-Myers Squibb.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page